D
Emergent BioSolutions Inc. EBS
$8.71 -$0.49-5.33% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 139.50M -131.60M -190.60M -208.80M -587.00M
Total Depreciation and Amortization 101.30M 106.30M 108.80M 112.40M 114.00M
Total Amortization of Deferred Charges 200.00K 2.80M 7.40M 10.90M 23.30M
Total Other Non-Cash Items -29.30M 65.10M 44.40M 39.40M 309.70M
Change in Net Operating Assets -42.70M 67.50M 88.70M 216.80M 217.00M
Cash from Operations 169.00M 110.10M 58.70M 170.70M 77.00M
Capital Expenditure -14.00M -15.70M -22.90M -32.60M -39.40M
Sale of Property, Plant, and Equipment 96.10M 76.00M 7.90M 7.60M --
Cash Acquisitions -- -- -- -- --
Divestitures 110.20M 110.20M 110.20M 110.20M 0.00
Other Investing Activities 25.00M 25.00M 30.00M 0.00 -6.30M
Cash from Investing 217.30M 195.50M 125.20M 85.20M -45.70M
Total Debt Issued 219.00M 234.00M 284.00M 304.00M 85.00M
Total Debt Repaid -413.00M -473.50M -482.40M -498.30M -128.20M
Issuance of Common Stock 10.90M 10.90M 10.80M 10.70M 1.40M
Repurchase of Common Stock -8.20M -1.30M -1.20M -1.00M -800.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 4.70M -1.20M -1.20M -1.20M -5.90M
Cash from Financing -186.60M -231.10M -190.00M -185.80M -48.50M
Foreign Exchange rate Adjustments 300.00K -700.00K -- -1.50M -400.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 200.00M 73.80M -6.10M 68.60M -17.60M